Overview

Evaluation of Pharmacokinetic/Pharmacodynamic Properties and Safety of Leucostim® Compared to Neupogen® in Healthy Adult Volunteers

Status:
Completed

Trial end date:
2016-05-01

Target enrollment:

Participant gender:

Summary

A Randomized, Open-label, Two-way Crossover, Open-label Clinical Trial to Compare Pharmacokinetic/Pharmacodynamic Properties and Safety after Subcutaneous Administration of Leucostim® and Neupogen® in Healthy Adult Volunteers

Phase:

Phase 1

Details

Lead Sponsor:

Dong-A ST Co., Ltd.

Treatments:

Lenograstim